Literature DB >> 29380284

123I-mIBG: Simplicity and reproducibility.

Kevin Curl1, Christopher L Hansen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29380284     DOI： 10.1007/s12350-018-1196-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  30 in total

Review 1.  Catecholamines and their blockade in congestive heart failure.

Authors:  C M White
Journal:  Am J Health Syst Pharm       Date:  1998-04-01       Impact factor: 2.637

2.  Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.

Authors:  Arnold F Jacobson; Roxy Senior; Manuel D Cerqueira; Nathan D Wong; Gregory S Thomas; Victor A Lopez; Denis Agostini; Fred Weiland; Harish Chandna; Jagat Narula
Journal:  J Am Coll Cardiol       Date:  2010-02-25       Impact factor: 24.094

Review 3.  Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections.

Authors:  Wengen Chen; Qi Cao; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

4.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.

Authors:  E B Henderson; J K Kahn; J R Corbett; D E Jansen; J J Pippin; P Kulkarni; V Ugolini; M S Akers; C Hansen; L M Buja
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

5.  Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy.

Authors:  J Schofer; R Spielmann; A Schuchert; K Weber; M Schlüter
Journal:  J Am Coll Cardiol       Date:  1988-11       Impact factor: 24.094

6.  Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy.

Authors:  Yuichi Kamiyoshi; Yoshikazu Yazaki; Kazutoshi Urushibata; Tomonori Koizumu; Hiroki Kasai; Atsushi Izawa; Osamu Kinoshita; Minoru Hongo; Uichi Ikeda
Journal:  Am J Cardiol       Date:  2008-03-26       Impact factor: 2.778

7.  Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine.

Authors:  D M Wieland; J Wu; L E Brown; T J Mangner; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1980-04       Impact factor: 10.057

8.  Myocardial imaging in man with I-123 meta-iodobenzylguanidine.

Authors:  R C Kline; D P Swanson; D M Wieland; J H Thrall; M D Gross; B Pitt; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-02       Impact factor: 10.057

Review 9.  Cardiac autonomic imaging with SPECT tracers.

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2013-02       Impact factor: 5.952

10.  Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure.

Authors:  Caroline E Veltman; Mark J Boogers; Joris E Meinardi; Imad Al Younis; Petra Dibbets-Schneider; Ernst E Van der Wall; Jeroen J Bax; Arthur J H A Scholte
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-07-13       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.